Aspen Aerogels, Inc. (NYSE:ASPN) Shares Sold by Federated Hermes Inc.

Federated Hermes Inc. trimmed its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 36.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 630,500 shares of the construction company’s stock after selling 368,100 shares during the quarter. Federated Hermes Inc.’s holdings in Aspen Aerogels were worth $7,490,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. AlphaQuest LLC lifted its holdings in shares of Aspen Aerogels by 54.0% in the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after buying an additional 3,998 shares during the period. KLP Kapitalforvaltning AS bought a new stake in Aspen Aerogels in the fourth quarter worth about $164,000. Journey Strategic Wealth LLC acquired a new stake in Aspen Aerogels in the 4th quarter valued at about $178,000. Ballentine Partners LLC grew its stake in shares of Aspen Aerogels by 19.2% in the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock worth $189,000 after purchasing an additional 2,565 shares during the last quarter. Finally, Aigen Investment Management LP bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $219,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Price Performance

Shares of ASPN opened at $5.12 on Friday. The business’s 50-day moving average is $7.72 and its 200-day moving average is $13.25. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The company has a market capitalization of $419.97 million, a price-to-earnings ratio of 31.97 and a beta of 2.35. Aspen Aerogels, Inc. has a fifty-two week low of $4.80 and a fifty-two week high of $33.15.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Equities research analysts expect that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ASPN shares. B. Riley reduced their target price on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a report on Wednesday, February 19th. Canaccord Genuity Group reduced their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Craig Hallum cut their target price on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Barclays decreased their price target on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research report on Wednesday, February 19th. Finally, Roth Mkm cut their price objective on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.11.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.